Data as of Aug 29
| +0.01 / +0.30%|
The 6 analysts offering 12-month price forecasts for OncoGenex Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 14.00 and a low estimate of 4.50. The median estimate represents a +141.69% increase from the last price of 3.31.
The current consensus among 6 polled investment analysts is to Buy stock in OncoGenex Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.